SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing extreme volatility and heavy short-selling pressure, with investors aggressively debating whether the stock is undergoing a permanent collapse or a temporary shakeout after a rapid, parabolic run. Market participants are fixated on the frequent trading halts, the intense conflict between retail bulls looking for a bounce and shorts capitalizing on the sharp downside move, and broader concerns regarding the company's valuation.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is currently trending due to intensifying speculation surrounding a potential shift in federal marijuana policy, with traders closely monitoring reports of a pending reclassification from Schedule I to Schedule III. Community discourse is highly polarized, as retail investors debate whether this development marks a sustainable shift toward long-term sector growth or if it is merely another volatile catalyst susceptible to a 'sell the news' reversal.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing significant volatility and increased bullish sentiment following its latest quarterly update, which highlighted progress on pilot production and expansion into new markets like AI data centers and defense. The community remains deeply divided, with long-term investors pointing to these strategic pivots as signs of maturation while active traders debate the impact of heavy short interest and the lack of traditional, large-scale commercial revenue.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as the stock faces sharp downward pressure following quarterly results, where investors reacted negatively to margin guidance and management's citation of geopolitical headwinds in the Middle East. While many community members view the dip as an overreaction to fundamentally strong AI-driven growth, others are actively debating whether the software sector is undergoing a broader valuation reset and AI-driven disruption.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors in this leveraged inverse semiconductor ETF are expressing significant frustration as an unprecedented, multi-week rally in the chip sector continues to erode value and trigger persistent daily losses. The community is actively debating whether this extreme market behavior indicates a bubble fueled by algorithmic manipulation or a genuine, long-term super-cycle in AI-driven demand.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense community focus as traders debate its potential for a major breakout above the psychological $50 level, fueled by speculation surrounding unannounced hyperscaler partnerships and upcoming capacity energization. While bulls emphasize the company's expanding infrastructure moat and institutional accumulation, others remain cautious of volatility and potential dilution, keeping the stock at the center of a heated debate between AI-driven upside and short-term price manipulation concerns.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing intense volatility and downward pressure following the announcement of a new CEO, a move that has sparked widespread skepticism among investors concerned about the company's future growth and brand relevance. While some traders view the current price as an oversold opportunity for long-term accumulation, the broader community remains divided, with active discussions focused on leadership credibility, rising market competition, and the company's struggle to regain momentum.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma shares are experiencing intense volatility as investors weigh the company's long-term enterprise growth narrative against heavy short interest and concerns regarding AI-driven disruption. The community remains deeply polarized, with many buyers viewing the current price as a generational entry point, while others fear further downside pressure from competitive AI tools and upcoming share lockup expirations.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is experiencing significant volatility driven by a major share buyback program and investor debate over its AI-driven product strategy. While some traders are aggressively buying the dip as a contrarian play, others remain cautious about the long-term impact of AI disruption on core software revenue.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is currently trending as traders weigh record U.S. natural gas production and high storage levels against ongoing geopolitical uncertainty and regional conflict in the Middle East. The community is actively debating the disconnect between elevated global energy prices and the relative stagnation of domestic natural gas, with intense focus on whether seasonal inventory builds and contract rollovers will trigger a reversal or lead to further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 6.8% - Time to Sell?

Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Down 6.8% - Time to Sell...

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Receives Consensus Rating of "Moderate Buy" from Analysts

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine analysts that are presently covering the firm, MarketBeat.com...

Hennion & Walsh Asset Management Inc. Buys New Shares in Phathom Pharmaceuticals, Inc. $PHAT

Hennion & Walsh Asset Management Inc. bought a new position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 114,981 shares of the company's stock, valued at appro...

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Up After Analyst Upgrade

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Up on Analyst Upgrade...

Phathom Pharmaceuticals (NASDAQ:PHAT) Upgraded at Barclays

Barclays raised shares of Phathom Pharmaceuticals from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $16.00 to $18.00 in a report on Friday...

Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study

OCGN stock falls after phase II data for OCU410 show lower lesion reduction than earlier results, despite 31% improvement in the eye disease study.

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

IBRX stock jumps after China approves Anktiva combo therapy for bladder cancer, marking its first Asia nod and expanding global reach to 34 markets.

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Given Average Recommendation of "Moderate Buy" by Brokerages

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Get Free Report) has earned an average rating of "Moderate Buy" from the nine analysts that are currently covering the firm, Marketbeat reports. One...

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

PBYI stock drops over 9% as weak 2026 revenue guidance and heavy reliance on Nerlynx raise concerns despite modest sales growth.

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli

MIRM completes enrollment in phase III EXPAND study of Livmarli for treating additional rare cholestatic liver diseases. Top-line data due in Q4 2026.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Current Price	$11.56
Prev Close	$11.73
Open	$11.99
Dividend Yield	0.00%
50-Day Moving Average	$11.61
Beta	1.22
Avg. Volume	1.14M
PE Ratio	-3.84

52-Week High	$18.31
52-Week Low	$2.21
Market Capitalization	$924.31M
EPS (Annual)	-$3.03
Price to Book	-1.91
Revenue Per Employee	$471,994.61

PHAT
Phathom Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PHAT News

PHATPhathom Pharmaceuticals Inc